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Abstract
Background: There is considerable clinician and researcher interest in whether the outcomes for patients with low 
back pain, and the efficiency of the health systems that treat them, can be improved by 'subgrouping research'. 
Subgrouping research seeks to identify subgroups of people who have clinically important distinctions in their 
treatment needs or prognoses. Due to a proliferation of research methods and variability in how subgrouping results 
are interpreted, it is timely to open discussion regarding a conceptual framework for the research designs and statistical 
methods available for subgrouping studies (a method framework). The aims of this debate article are: (1) to present a 
method framework to inform the design and evaluation of subgrouping research in low back pain, (2) to describe 
method options when investigating prognostic effects or subgroup treatment effects, and (3) to discuss the strengths 
and limitations of research methods suitable for the hypothesis-setting phase of subgroup studies.
Discussion: The proposed method framework proposes six phases for studies of subgroups: studies of assessment 
methods, hypothesis-setting studies, hypothesis-testing studies, narrow validation studies, broad validation studies, 
and impact analysis studies. This framework extends and relabels a classification system previously proposed by 
McGinn et al (2000) as suitable for studies of clinical prediction rules. This extended classification, and its descriptive 
terms, explicitly anchor research findings to the type of evidence each provides. The inclusive nature of the framework 
invites appropriate consideration of the results of diverse research designs. Method pathways are described for studies 
designed to test and quantify prognostic effects or subgroup treatment effects, and examples are discussed. The 
proposed method framework is presented as a roadmap for conversation amongst researchers and clinicians who 
plan, stage and perform subgrouping research.
Summary: This article proposes a research method framework for studies of subgroups in low back pain. Research 
designs and statistical methods appropriate for sequential phases in this research are discussed, with an emphasis on 
those suitable for hypothesis-setting studies of subgroups of people seeking care.
Background
Several authors [1,2] have argued that low back pain is
most accurately classified as pain associated with serious
pathology, pain associated with nerve compression, or
non-specific low back pain (NSLBP). Under this
approach, approximately 80% of low back pain in primary
care is classified as NSLBP [1] and investigations into
treatment efficacy for this condition have identified only
moderate treatment effects.
However, most clinicians [3,4] and researchers [3]
believe NSLBP to be a number of conditions, and sub-
grouping NSLBP is currently of clinical and research
interest [5-10]. This interest is premised on the notion
that patient outcomes might be improved with more pre-
cise targeting of treatment, and health system efficiency
might be improved with more effective triage of patients.
Many NSLBP subgrouping systems have been pro-
posed. Some aim to identify people whose pain is associ-
ated with a particular pathoanatomical condition, based
on their presenting symptoms and signs (diagnostic sub-
groups) [11,12]. Other systems aim to identify people
likely to respond favourably to particular treatment regi-
mens (treatment effect modifier subgroups) [13-15],
while other systems aim to identify people with particular
prognoses (prognostic factor subgroups) - such as those
at risk of chronicity [10]. While there is no shortage of
opinions about the composition of clinically important
NSLBP subgroups, there is very little consensus regarding
the symptoms and signs that identify these subgroups
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into three broad stages of research: exploratory studies
that seek to identify subgroups, studies that attempt to
validate subgroups and studies that test the capacity of
subgrouping to positively influence routine clinical care
[17]. The research designs and statistical methods appro-
priate for subgrouping studies vary depending on
whether the aim of the subgrouping is prognostic, thera-
peutic or diagnostic, and also vary depending on the
stage of the research.
Subgrouping research is fraught with methodological
pitfalls and many authors have described reasons for cau-
tion in the conduct, interpretation and reporting of such
studies [18-22]. In this context, there has been a prolifera-
tion of subgrouping studies in NSLBP, most of which have
been hypothesis-setting and they report highly variable
methods. Even among studies that report similar meth-
ods, their authors may have different opinions about the
level of evidence these studies are capable of providing.
Therefore, in subgrouping research not only is method-
ological rigor very important but there is also a need for
an accepted method framework in which to classify, eval-
uate and discuss this research with a common vocabulary.
The aims of this debate article are to present a method
framework for conducting and evaluating subgrouping
research in low back pain, and to discuss the strengths
and limitations of research methods suitable for hypothe-
sis-setting studies. The focus of the article is on research
method and where appropriate, examples of studies are
used to illustrate concepts. However, this article is not a
review of the findings of subgrouping research and other
examples of studies may have been equally appropriate.
Discussion
Prognostic factors, treatment effect modifiers and clinical 
prediction rules
In this proposal we adopt earlier recommendations in
distinguishing between prognostic factors and treatment
effect modifiers [23,24]. Prognostic factors are symp-
toms, signs or other characteristics that indicate likely
outcomes regardless of treatment. Treatment effect mod-
ifiers are symptoms, signs or characteristics that indicate
likely response to a specific treatment (a subgroup treat-
ment effect). This distinction has important implications
for the methods suitable for research of subgroups.
Patient outcomes are usually the product of a combina-
tion of treatment effects and prognostic factor effects,
unless the treatment is completely ineffective. Therefore,
studies need to use particular designs if these effects are
to be teased apart. It has been reported that this distinc-
tion is commonly misunderstood [23].
Prognostic factors
The effect of prognostic factors can be studied in data
from cohort studies ('single-group' designs) of usual care.
Usual care implies that treatments are various, uncon-
trolled and reflective of common practice. Under these
circumstances, it is assumed that the heterogeneity of
treatments washes out specific treatment modifier
effects. In contrast and at the other extreme, when pre-
dictors of outcome are investigated in cohort studies in
which all participants receive only one treatment, it is not
possible to differentiate between which factors predictive
of outcome are prognostic factors and which are effect
modifiers specific to that treatment [23].
Prognostic factors have also been studied using data
from randomised controlled trials ('two-group' designs).
One approach is to study predictive factors only in a con-
trol group that received either placebo care or usual care.
Conceptually, this is similar to a prospective cohort study.
Another approach is to study (as a single group) the
whole cohort from a trial that showed no differences in
outcome for the experimental and the control treatments.
Where the control treatment was not placebo or no treat-
ment, this latter approach is problematic if the treatments
had a clinical effect, as the predictive factors may contain
treatment effect modifiers common to both treatments.
The generalisability of findings from studies of prognostic
factors are always limited by the selection criteria of the
study, and clinical trials tend to have more restrictive
inclusion criteria than cohort studies. Contemporary
summaries are available of key methodological issues for
cohort studies of prognostic factors [18,20,25,26].
Treatment effect modifiers
In contrast, the precise measurement of treatment effect
modifiers requires data from randomised controlled trials
[27]. The appropriate trial design varies depending on the
type of research question being investigated. As precise
identification of the presence of treatment effect modifi-
cation requires a test of subgroup/treatment effect inter-
action, currently only two designs for controlled trials are
well suited for measuring treatment modifier effects
[23,28,29]. Examples of such studies are those by Childs
et al (2004) [14] and Brennan et al (2006) [13]. There are a
number of concise summaries available for readers who
are seeking greater detail on methodological issues for
randomised controlled trials in which treatment effect
subgroup analysis is planned [19,21-24,30].
Clinical prediction rules
Whether used in the investigation of prognostic factors
or treatment effect modifiers, many statistical techniques
produce measures of association that can be difficult for
clinicians to apply to individual patients. In response to
this, clinical prediction rules are increasingly being used
as a means to express the likely response of a subgroup in
clinically interpretable ways. They also allow the accuracy
of this predictive capacity to be described [31]. A method
for forming a prediction rule is detailed in Additional File
1.
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The proposed method framework classifies subgrouping
studies into six phases of research: studies of assessment
methods, hypothesis-setting studies, hypothesis-testing
studies, narrow validation studies, broad validation stud-
ies, and impact analysis studies. These are defined in Fig-
ure 1. This framework extends descriptive terms
previously suggested by McGinn et al (2000) [17] as suit-
able for classifying studies of clinical prediction rules. It
does so by adding an initial phase of 'studies of assess-
ment methods', and by splitting the process described by
McGinn as 'derivation studies' into two phases: hypothe-
sis-setting studies and hypothesis-testing studies.
Extending and modifying these phases in the proposed
framework was undertaken to achieve a number of pur-
poses. The first purpose was to allow categorisation of an
increasing number of studies that seek to devise measures
of subgroup-specific characteristics, especially measures
of physical impairment. The second purpose was to bet-
ter describe the quality of evidence provided by studies in
the pre-validation phases, in recognition that authors
were interpreting that quality in different and contradic-
tory ways. The third purpose was to broaden the frame-
work to include subgrouping studies that do not express
findings using clinical prediction rules.
Phases of research into subgroups
Studies of assessment methods Within the proposed
method framework, the first phase in subgrouping
research comprises studies that attempt to create or
improve tools that assess clinical characteristics poten-
tially indicative of subgroup membership, or to determine
the measurement properties (clinimetrics) of those tools.
Guidance is available on suitable research designs and
statistical methods to perform such studies [32-36]. An
example of a study of a novel tool for assessing potential
subgroup membership is Ferreira et al (2004)[37], which
investigated an ultrasound test to measure, in clinical set-
tings, the automatic recruitment of trunk muscles in peo-
ple with low back pain.
Hypothesis-setting studies The second phase (hypothe-
sis-setting) is represented by studies that attempt to
determine which characteristics identify people in clini-
cally important subgroups, and the magnitude of any
prognostic effects or treatment effect modification attrib-
utable to these subgroups. Other authors have argued
that treatment effect modifiers can only be determined in
randomised controlled trials[23] and that the probability
(p value) of treatment responses associated with specific
subgroups should be adjusted to reflect multiple statisti-
cal comparisons[24]. We suggest that within a hypothe-
sis-generating phase, these criteria can be relaxed and
instead applied later during rigorous hypothesis-testing
studies. For example, we suggest that during this explor-
atory phase, data from cohort studies may generate useful
hypotheses about potential treatment effect modifiers
(for example Flynn et al 2004), and that it is permissible
to perform post-hoc multiple comparisons without Bon-
ferroni-type corrections.
Hypothesis-testing studies The third phase (hypothe-
sis-testing) in subgrouping research comprises studies
that test pre-specified (a priori) hypotheses about sub-
grouping effects in samples of people independent from
but similar to those people who participated in the
hypothesis-setting phase. During this confirmatory phase
Figure 1 Conceptual phases of research into subgroups
Studies of 
assessment methods
Study designs
Studies of test/retest (intra-rater) 
reliability, inter-rater reliability, 
responsiveness, acceptability and 
feasibility.
Head to head comparisons of 
similar measurement methods.
Hypothesis-setting studies Hypothesis-testing studies Broad validation studies Impact analysis studies
Study designs
Cohort studies (single group 
designs).
Study designs
Randomised controlled trials 
(two group designs),
Study designs
Cohort studies (single group 
designs).
Study designs
Randomised controlled trials 
(two group designs),
Study designs
Randomised controlled trials 
(two group designs),
Time-series designs.
Study designs
Randomised controlled trials 
(two group designs).
Time-series designs.
Study designs
Cross-sectional or longitudinal 
analysis of data from cohort 
studies (single-group designs) 
or from randomised controlled 
trials (two or more group 
designs).
Studies that attempt to 
replicate the fi ndings of 
hypothesis testing studies 
in independent samples 
of patients from broader 
populations than originally 
tested. These measure the 
generalisability of a subgroup 
effect.
Studies that examine, 
in routine care settings, 
the capacity of a specifi c 
subgrouping method to 
change clinician behaviour, 
improve patient outcomes 
and increase health system 
effi ciency.
Studies that test pre-specifi ed 
(a priori) hypotheses about 
subgrouping effects and 
use statistical analysis 
that adjusts for multiple 
comparisons. Such studies 
must include pre-planned 
and appropriate subgroup 
analyses that are adequately-
powered.
Studies that attempt to detect 
characteristics that identify 
people who:
a) respond differently to 
specifi c treatment (treatment 
effect modifi ers),
b) regardless of treatment, 
recover at different rates 
or have a higher likelihood 
of a particular outcome, 
(prognostic factors),
c) have an increased 
probability of their pain 
being related to a particular 
pathoanatomical
structure (diagnostic 
subgroups)
Studies that:
a) attempt to create or 
improve tools that assess 
clinical characteristics 
potentially indicative of 
subgroup membership, 
b) measure or improve 
the reliability, validity and 
responsiveness of methods 
to measure symptoms, signs, 
physiological markers 
and outcomes.
Hypotheses 
regarding 
prognostic 
factors
Hypotheses 
regarding 
treatment
effect 
modifi ers
Treatment effect modifi er pathway
Prognostic factor pathway
Legend:
Narrow validation studies
Study designs
Cohort studies (single group 
designs).
Study designs
Randomised controlled trials 
(two group designs),
Studies that attempt to 
replicate the fi ndings of 
hypothesis testing studies 
in independent samples of 
patients who are similar to 
those originally tested. These 
measure the variability in a 
subgroup effect.
Hypothesis-setting studies - 
for more detail on method see 
Figures 2a and 2b
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fied hypotheses and for appropriate statistical adjustment
for multiple comparisons. We believe that this distinction
between hypothesis-setting and hypothesis-testing stud-
ies would reconcile differences in interpretation as to the
quality of evidence of subgroup effect that particular
studies provide.
Replication of prognostic effects or treatment effect
modifion in an independent sample under stringent
research conditions is the central aim of hypothesis-test-
ing studies and is a method of external validation. The
chance of spurious, sample-specific effects or associa-
tions in hypothesis-setting studies is so high in subgroup-
ing research, that Rothwell (2005) [19] suggests that the
best test of the validity of subgroups is not significance
testing but replication in an independent sample. Quasi-
replication within the hypothesis-setting stage by use of
iterative statistical techniques (such as boot-strapping) is
an inadequate substitute for replication in an indepen-
dent sample [17,38]. This is because the repeated testing
of findings on sub-samples of the original data only par-
tially counters problems associated with sample-specific
relationships between predictors and outcomes, as they
are test a relationship in the cohort in which the relation-
ship was first established.
Narrow validation studies The fourth phase (narrow
validation) comprises studies that attempt to validate the
findings of hypothesis-testing studies in samples of peo-
ple who are independent from, but similar to, those who
participated in the hypothesis-testing phase. Such studies
provide insight into the variability of a subgroup effect in
the target population [27].
Broad validation studies The fifth phase (broad valida-
tion) comprises studies that test the findings of hypothe-
sis-testing studies in samples of people who differ from
those who previously participated. The clinical character-
istics of these samples of patients may differ on dimen-
sions such as the spectrum of the disorder, demographic
and psychosocial profile, culture and language, co-mor-
bidities and care settings (primary/secondary/tertiary
care). Similarly, the experience, training and professional
discipline of the clinicians may vary from those providing
care in earlier studies. Broad validation establishes the
generalisability of the subgroup findings beyond the clini-
cal and professional profile of the people originally stud-
ied [17].
Impact analysis studies The sixth and last phase (impact
analysis) comprises studies that seek to establish the fea-
sibility of uptake of the subgrouping scheme in practice
and the capacity of subgrouping to improve outcomes in
routine clinical care. Subgroups that have been shown to
have predictive capacity in hypothesis-testing and valida-
tion studies may still not be effectively implemented in
routine care, due to issues such as perceived importance
by clinicians, patient-perceived acceptability and the
practicality of assessing predictor variables [26,39].
Methods for performing hypothesis-setting studies of 
subgrouping
Most of the subgrouping studies in low back pain have
been hypothesis-setting and they have used highly vari-
able research designs and statistical methods. We have
classified these designs and methods into three catego-
ries. The purpose of the categories is to clarify suitable
method pathways in hypothesis-setting studies, although
it is possible that studies may exist that contain elements
from more than one pathway.
Subgroups based on opinion (clinical observation)
The first of these categories is opinion-based subgroups
that originate from clinical observation. An example is
the McKenzie subgroup of patients who display a direc-
tional preference [40], which was initially based on an
astute clinical observation that some people display pain
that responds to particular movements.
Subgroups based on physiological/psychosocial models that 
are derived from experimental observation
The second category is subgroups based on physiologi-
cal/psychosocial constructs that are derived from experi-
mental observation. An example is O'Sullivan's
'Mechanism-based classification' [41].
We argue that within the hypothesis-setting phase,
opinion-based subgroups and subgroups based on exper-
imental constructs need to be formally tested for treat-
ment modification effects using appropriately designed
randomised controlled trials, and/or tested for prognos-
tic effects using a cohort study design. Method pathways
for opinion-based subgroups and subgroups based on
physiological/psychosocial experimental constructs are
shown in Figure 2.
'Data-driven' subgroups based on statistical analysis
The third category of designs and methods used in
hypothesis-setting studies is 'data-driven' subgroup anal-
ysis, where data from cohort studies or randomised con-
trolled trials are investigated using cross-sectional
statistical analysis, or investigated using longitudinal sta-
tistical analysis. These forms of analysis are called 'data-
driven' because a subgroup is being formed retrospec-
tively (post-hoc) from the characteristics of the sample
data [22], rather than on clinical observation or a physio-
logical/psychosocial experimental model. Method path-
ways for data-driven subgroups are shown in Figure 3.
Data-driven subgroups can be identified in two ways:
either in relation to an outcome or by identifying vari-
ables that are associated with each other without regard
to an outcome. Statisticians call these two main classes of
statistical approaches 'supervised' techniques and 'unsu-
pervised' techniques respectively. Both have methodolog-
ical advantages and disadvantages. The first main class of
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these techniques work backwards from an outcome in
longitudinal data, such as people classified as responders
or non-responders to a treatment regimen. Examples of
supervised statistical techniques include regression anal-
ysis, discriminant function analysis, recursive partition-
ing analysis, and classification and regression trees. The
other main class of statistical techniques used in data-
driven subgrouping is called 'unsupervised' because these
techniques do not work backwards from an outcome but
instead look for relationships between measurable char-
acteristics inherent in cross-sectional data. Examples of
unsupervised statistical techniques include cluster analy-
sis, data-mining and neural networks.
A sub-class of statistical techniques are known by stat-
isticians as 'clinimetric' techniques. These techniques
include sensitivity, specificity, likelihood ratios, odds
ratios, risk ratios and pre- and post-test probability. In
hypothesis-setting studies of subgroups of low back pain,
one set of circumstances where these statistical tech-
niques have been used is with cross-sectional data. An
example is when seeking to identify the clinical character-
Figure 2 Flowchart for hypothesis-setting studies of subgroups based on opinion or based on physiological models
Hypotheses regarding 
prognostic factors
Hypotheses regarding 
treatment effect modifi ers
Testing of subgroups for 
prognostic effects 
Study design
Longitudinal cohort study 
with subgroup membership 
as predictor of outcome
(single group study)
Testing of subgroups for 
treatment effect modifi ers 
Study design
Randomised controlled trials of 
two treatments, analysed with 
tests of interaction between 
treatment and subgroup 
membership (two group study)
Proceed to hypothesis-testing studies
Subgroups based on 
opinion
Subgroups based on experimental
physiological/psychosocial constructs
Hypotheses regarding 
subgroups
Treatment effect modifi ers pathway
Prognostic factor pathway
Legend:
Hypothesis-setting phase
Hypotheses regarding 
subgroups
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('diagnostic' subgroups). Another circumstance where
these statistical techniques have been used is within the
formation of clinical prediction rules. For example, where
subgroup characteristics have been identified using other
methods, they have been used to determine the optimal
combination of predictor variables that provides the
greatest classification accuracy.
Data-driven subgroups from the analysis of longitudinal data 
- using 'supervised' statistical techniques
In hypothesis-setting subgrouping analysis of longitudi-
nal data, the most common data-driven approach is the
Figure 3 Flowchart for hypothesis-setting studies of subgroups based on 'data-driven' analysis
Using ‘supervised’* statistical techniques 
such as regression analysis,
discriminant function analysis,
recursive partitioning analysis, 
classifi cation and regression tree analyisis
and/or clinimetric statistics
Hypotheses regarding 
prognostic factors
 Data-driven subgroups based on analysis of data from cohort studies (single-group 
designs) or randomised controlled trials (two or more group designs)
Using ‘unsupervised’* statistical 
techniques such as cluster analysis,
data-mining, neural networks
Hypotheses regarding 
treatment effect modifi ers
Hypotheses regarding subgroups
Testing of subgroups for 
prognostic effects 
Study design
Longitudinal cohort study 
with subgroup membership 
as predictor of outcome
(single group study)
Testing of subgroups for 
treatment effect modifi ers 
Study design
Randomised controlled trials of two 
treatments, analysed with tests of 
interaction between treatment and 
subgroup membership (two group study)
Proceed to hypothesis-testing studies
Hypotheses regarding 
treatment effect modifi ers 
Hypotheses regarding 
prognostic effects 
Using ‘clinimetric’# statistical 
techniques such as sensitivity, 
specifi city, likelihood ratios, odds 
ratios, risk ratios
Analysis of cross-sectional data Analysis of longitudinal data
From cohort studies
(single-group designs)
From randomised controlled trials
(two or more group designs)
Treatment effect modifi er pathway
Prognostic factor pathway
Legend:
Hypothesis-setting phase
Tentative hypotheses 
regarding treatment 
effect modifi ers 
‘Supervised’ statistical techniques work backwards from 
an outcome, such as people classifi ed as having a good or 
poor outcome.
‘Unsupervised’ techniques look for relationships between 
measurable characteristics inherent in cross-sectional data.
*
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such a study is the formation of the Flynn manipulation
prediction rule [42]. In this cohort study, a group of peo-
ple who all received the same treatment (spinal manipula-
tion and range-of-motion exercises) was investigated
with the aim of constructing a clinical prediction rule
capable of identifying people likely to improve with this
treatment. Logistic regression was used to determine
which symptoms and signs were predictive of people who
improved, and clinimetric statistics were used to deter-
mine what combination of those symptoms and signs
provided the greatest predictive capacity (Figure 4). Being
a cohort study, hypotheses formed about treatment effect
modifiers could only be tentative, as such a study design
cannot clearly differentiate between treatment effect
modifiers and prognostic factors.
However, subsequent to this study, Childs et al (2004)
[14] performed a randomised controlled trial, in which a
treatment modifier effect of the Flynn manipulation pre-
diction rule was demonstrated using a test of subgroup/
treatment/time interaction. In this example, the tentative
hypothesis regarding treatment effect modifiers was
formed in a cohort study and then demonstrated in a sub-
sequent randomised controlled trial, using a test of inter-
action. In the proposed method framework, these two
studies would be categorised as sequential steps in the
hypothesis-setting phase. Had the initial study been a
randomised controlled trial, the hypothesis formation
could have occurred in a single study. The method for
such a single study is shown in Figure 5.
The Childs (2004) study examined the treatment modi-
fication effect of the entire set of five symptoms and signs
in the Flynn manipulation prediction rule. Due to the
possibility that a prediction rule derived from a cohort
study may contain some predictors that are treatment
effect modifiers and some that are prognostic factors, it
would be ideal for there to be a mechanism to tease these
apart. One way is to perform retrospective (post-hoc)
exploratory analysis on the individual symptoms or signs
that were included in a randomised controlled trial. Using
the Childs (2004) data [14], Fritz et al (2005) [43] did for
this one item in the Flynn manipulation prediction rule
and showed, using a test of subgroup/treatment interac-
tion, a treatment modifier effect of lumbar spine segmen-
tal hypomobility. Theoretically, this post-hoc analysis
could be performed on all the prediction rule items to
identify which are treatment effect modifiers and further
refine the prediction rule.
Strengths and weaknesses An important advantage of
subgrouping studies that use supervised statistical tech-
niques to analyse longitudinal data, is that the subgroup
has immediate face validity. This is because the subgroup
is formed using a clinically relevant dependent (outcome)
variable and therefore the clinical utility of the subgroup
is readily apparent. A characteristic of supervised tech-
niques is that clinical prediction rules based on the
results of such research are usually dependent on a single
outcome and therefore this type of research may lead to a
proliferation of competing prediction rules. For example,
a clinical prediction rule for the outcome of 'return-to-
work' may be quite different from a clinical prediction
rule for the outcome of 'moderate or more pain', even if
the cohort of people, the treatment and the time period of
interest are all the same. This is because outcomes such
as 'return-to-work' are influenced by other factors than
those that are associated with pain reduction, such as the
availability of alternative duties or workplace support
structures. Similarly, a prediction rule formed when com-
paring two treatments may not be the same when the
comparison treatment is different. In addition, the pre-
diction rule for a monotherapy (such as manipulation)
may not hold when that therapy is applied in combination
with other treatment (such as manipulation and exercise).
Moreover, treatment effects can be time-dependent, and
so prediction rules for the same treatment may vary
depending on the time period over which participants are
studied. Therefore, supervised analysis is likely to result
in multiple clinical prediction rules for the same cohort of
people and rules that also vary across cohorts of people.
A number of subgrouping studies have used supervised
analysis techniques, such as logistic regression, in forms
that can only model two subgroups. This is appropriate
for modelling dichotomous subgroups, such as respond-
ers and non-responders. However, in circumstances
where more than two subgroups are to be modelled,
other techniques, such as polytomous or multinomial
forms of logistic regression, could be used. For example,
where a therapy was expensive and had significant side
effects, it might be desirable to identify people very likely
to respond, people less likely to respond and those very
unlikely to respond. In this case, these subgroups could
be used to triage people into 'good candidate for this
treatment', possible candidate under particular circum-
stances' and 'poor candidate for this treatment'. Hypo-
thetically, such a therapy in low back pain might be the
use of TNF-inhibitor medication for anklyosing spondyli-
tis.
Data-driven subgroups from the analysis of cross-sectional 
data - using 'unsupervised' statistical techniques
One data-driven approach to analysing cross-sectional
data for subgroups is the use of 'unsupervised' statistical
techniques. As seen earlier, unsupervised techniques do
not work backwards from an outcome but are instead
used to look for inherent relationships between measur-
able characteristics in cross-sectional data.
An example of a subgrouping hypothesis-setting study
that used a data-driven unsupervised statistical technique
on cross-sectional data is that by Scholtz et al 2009 [44].
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Figure 4 Example of the use of a 'supervised' statistical technique (logistic regression) on longitudinal data in a hypothesis-setting cohort 
study (single-group design).
Total sample of
participants
  Variables          Variables 
  associated with       not
  people who      associated
  improved 
  Variables      Variables
  retained in      not
  multivariable       retained
  model  
Bivariate analysis 
Chi-square tests for dichotomous 
variables
Kruskal-Wallis tests for categorical 
variables
T-tests for  continuous variables
Multivariable analysis 
Logistic regression
Hypothesis regarding 
symptoms and signs that 
identify people likely to 
improve
*The participants scores on the outcome measure are dichotomised into those people that 
improved and those that did not improve (however improvement is defi ned). 
To form a hypothesis about symptoms and signs that potentially identify people likely to 
improve with a particular treatment (treatment effect modifi ers), participants are exposed to 
only one type of treatment. A tentative hypothesis formed in this way requires a subsequent 
randomised controlled trial to demonstrate that these are treatment effect modifi ers.
To determine symptoms and signs that identify people likely to improve regardless of treatment 
(prognostic factors), participants are exposed to diverse treatments, such as in usual care.
Method modifi ed from Flynn et al (2002).
          People 
classifi ed 
as improved*
 People 
classifi ed 
as not 
improved
Formation of prediction rule
Clinimetric statistics used to 
optimise clinical prediction rule
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Figure 5 Example of the use of 'supervised' statistical techniques (such as regression and ANOVA) on longitudinal data in a hypothesis-set-
ting randomised controlled trial (two-group plus subgroup covariate design).
Total sample of 
participants
Blinded randomisation
Test of interaction
between treatment allocation, 
prediction rule status and outcome
People who were rule-
positive & received 
control treatment
People who were rule-
positive & received 
target treatment
People who were rule-
positive & received 
control treatment
Target treatment Control treatment
People who were rule-
negative & received 
target treatment
This research design allows direct identifi cation of treatment effect modifi ers while controlling for 
prognostic effects. 
Outcomes
target treatment
Outcomes
control treatment
Analysis to identify a 
clinical prediction rule consisting 
of symptoms and signs that 
identify people likely to 
respond to the target treatment
Hypothesis regarding 
symptoms and signs that identify 
people likely to improve more 
with the target treatment than 
with the control treatment
and the size of that effect
Bivariate and multivariate analysis 
Such as regression analysis, 
discriminant function analysis,
recursive partitioning analysis, 
classifi cation and regression tree 
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be used to optimise a prediction rule
Retrospective (post-hoc)
identifi cation of rule status 
and treatment allocation
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Such as ANOVA to 
determine if a subgroup 
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regression to determine the 
effect size.
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Page 10 of 14In this study of a mixed cohort of people experiencing
pain but not necessarily low back pain, hierarchical clus-
ter analysis was used to identify six subgroups of people
with neuropathic pain and two subgroups of people with
non-neuropathic pain (Figure 6). In a second step, classi-
fication tree analysis was used to isolate which symptoms
and signs had the greatest discriminatory capacity to clas-
sify people into these subgroups. Though not undertaken
Figure 6 Example of the use of a 'supervised' statistical technique (cluster analysis) on cross-sectional data in a hypothesis-setting study.
Sub-group A
(characteristic 
symptoms 
and signs)
Sub-group D
(characteristic 
symptoms 
and signs)
Sub-group n
(characteristic 
symptoms 
and signs)
Sub-group B
(characteristic 
symptoms 
and signs)
Total sample of
participants
Cluster analysis used to detect
any ‘latent’ subgroups
Method modifi ed from Scholz et al (2009).
Hypothesis regarding 
symptoms and signs that 
identify people 
belonging to subgroups
Identifi cation of subgroups
Classifi cation and regression
tree analysis used to identify 
symptoms and signs that are 
characteristic of these subgroups 
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Page 11 of 14in this study, the next step within the hypothesis-setting
phase of our proposed method framework would be to
test these subgroups for treatment modifier or prognostic
effects using longitudinal data.
Strengths and weaknesses Unsupervised techniques
have some advantages: subgroups detected in this way
can later be studied against a range of treatments and
outcomes, subgroup formation is not dependent on only
one outcome, subgroup formation is not dependent on
the efficacy of current treatments, more than two sub-
groups can be detected in a single analysis, and some
unsupervised techniques, such as forms of data-mining,
also perform well in the presence of missing data. How-
ever, unsupervised techniques are more exploratory than
supervised techniques and subgroups are not modelled
using a clinical outcome. Therefore, they always require,
still within the hypothesis-setting phase, subsequent test-
ing against clinically important outcomes to determine if
they are clinically relevant. The major disadvantage of
this method is that it is possible, maybe probable, that
many subgroups derived using unsupervised techniques
have no clinical relevance.
Data-driven subgroups from the analysis of cross-sectional 
data - using 'clinimetric' statistical techniques
Another data-driven method of analysing cross-sectional
data for subgroups is the use of 'clinimetric' statistical
techniques. In this particular context, this method has
been used when researchers seek to detect symptoms and
signs that indicate an increased probability that a
patient's pain is associated with the presence of a particu-
lar pathoanatomic structure (diagnostic subgroup).
An example of a subgrouping hypothesis-setting study
that used data-driven 'clinimetric' statistical techniques
on cross-sectional data is Laslett et al 2005 [45]. In this
study, people with chronic low back pain seeking a diag-
nostic evaluation in a radiology clinic, were evaluated
using provocative discography and a clinical examination
by a skilled physiotherapist. The radiologist and physio-
therapist were blind to each other's results and the phys-
iotherapist was blind to previous imaging and injection
results. Clinimetric statistics were used to determine the
strength of association (diagnostic accuracy) between a
positive result on the provocative discography and each
of the other symptoms or signs (Figure 7). A clinical deci-
sion rule was then formed, consisting of the optimal com-
bination of those symptoms and signs that provided the
greatest predictive capacity. Again, though not under-
taken in this study, the next step within the hypothesis-
setting phase of our proposed method framework would
be to test these subgroups for treatment modifier or
prognostic effects.
Strengths and weaknesses It is understandable why this
'diagnostic' approach has appeal, as it mimics the Medical
Model that has been useful across broad areas of health
care. Typically in NSLBP the imaging and clinical find-
ings that have been associated with pathoanatomic struc-
tures capable of generating back pain have such a high
prevalence in the asymptomatic population that there is
considerable uncertainty as to whether they indicate the
source of pain in an individual symptomatic patient.
Therefore, this 'diagnostic' approach has used the pain
response to invasive tests, such as controlled facet injec-
tion or provocative discography, to determine the cer-
tainty with which a set of clinical symptoms and signs
indicate that an individual patient's pain arises from a
particular pathoanatomic structure [46-51]. The
approach of using pain response to injections in individu-
als to generalise to populations has been criticised for a
number of reasons, including the validity of using
response to injection as a reference standard, somato-
topic imprecision in the low back, selection bias, spec-
trum bias, and a lack of concordance in replication
studies. However, these criticisms relate more to the con-
struct, design and interpretation of these 'diagnostic'
studies than to the clinimetric statistics used.
Overfitting, data dredging and sample size
The findings of subgroup research can be erroneous if
overfitting or data dredging have occurred. Overfitting is
present when the statistical analysis contains too many
predictor variables for the size of the dataset. Though dif-
ferences of opinion exist, some authors have argued that
multivariable analysis requires at least 10 outcome events
per independent variable to avoid overfitting [52,53]. The
number of outcome events is the sum of the occurrences
of the outcome of interest in the data. For example, if the
outcome of interest were the people who had a very good
recovery, and 35% of a cohort of 300 people did recover
well, the number of outcome events is 105 (35% of 300)
and therefore, approximately 10 independent variables
could be simultaneously entered into a multivariable
analysis. The presence of overfitting will markedly
weaken the probability that the original findings are
reproduced in an independent sample.
Data dredging is the search in large data sets for chance
findings that are statistically significant and their report-
ing without testing if they are spurious associations
through replication in an independent data set. Overfit-
ting and data dredging reinforce the desirability of inde-
pendent sample replication before subgroup predictors
are given credence. This may prevent the clinical applica-
tion or further fruitless testing of chance findings.
Despite the importance of this step, a recent systematic
review of predictors of chronicity in NSLBP found that,
depending on the outcome measure used, only 1 in 12 to
1 in 30 included studies had tested their multivariable
findings in an independent sample [54].
All statistical methods for subgroup research require
larger sample sizes than studies that are powered to
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Figure 7 Example of the use of 'clinimetric' statistical techniques (sensitivity and specificity) on cross-sectional data in a 'diagnostic' hy-
pothesis-setting study.
Total sample of
participants
  Calculation of the
diagnostic accuracy of 
each individual 
symptom or sign
   Calculation of the
diagnostic accuracy of 
combinations 
of symptoms and signs
Determination of a
clinical decision rule 
for the optimal combination 
of symptoms and signs
‘Diagnostic’ analysis 
Using clinimetric statistics 
derived from contingency tables, 
such as: sensitivity, specifi city, 
likelihood ratios, positive and 
negative predictive values, receiver 
operating curves, pre- and post-test 
probability
Method modifi ed from Laslett et al (2005).
  
People whose pain was 
classifi ed as ‘positive’, 
for example, relieved 
with an injection of 
analgesic into a specifi c 
anatomical structure
People whose pain 
was classifi ed as 
‘negative’
Hypothesis regarding a 
combination of 
symptoms and signs that 
identify people with
a particular painful 
pathoanatomy
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Page 13 of 14detect effects observable in a whole group. For example,
two-group randomised controlled trials designed to
quantify the impact of treatment effect modifiers, require
approximately four times the sample size of a conven-
tional controlled trial powered to detect a main effect of
the same size [55]. Similarly, the variability present in
NSLBP is likely to warrant larger sample sizes in cohort
studies and 'diagnostic' studies, than in conditions where
the link between pain and pathology is stronger. Hancock
et al (2009) [23] have argued that estimates of treatment
effect modification require narrow confidence intervals
to be convincing. Narrower confidence intervals, whether
around point estimates of treatment effect modification,
prognostic risk or diagnostic accuracy, are measures of
increased certainty. Narrower confidence intervals allow
increased confidence in inferences about clinically
important subgroups but do not preclude the need for
validation studies.
The need for all phases of subgrouping research
All the research designs and statistical techniques shown
in the method pathways in Figures 2 and 3 have their
advocates and detractors. The perfect study has not been
conducted, as methods are constantly evolving. However,
if we are to determine whether subgroup-tailored treat-
ment or generic treatment is better clinical practice,
imperfect hypothesis-setting studies will need to be toler-
ated in the knowledge that further testing is required in a
rigorous hypothesis-testing phase and subsequent valida-
tion phases. Regardless of the methods used to form sub-
group hypotheses, whether these hypotheses concern
prognostic effects or treatment effects, there is a need to
continue through the other phases of subgrouping
research to determine whether these effects are repro-
ducible, generalisable and of clinical importance. Errone-
ous subgroup findings will not survive the challenge of
these later phases of investigation.
We propose that a commitment to the rigor implicit in
the method framework is a standard that all proponents
of subgroups should meet if subgroup hypotheses are to
have scientific credibility. Similarly, it could be argued
that subgroup findings that are still in the hypothesis-set-
ting stage are premature to market to clinicians, due to
the high probability of spurious findings.
Even where subgrouping findings have shown accept-
able reproducibility, generalisability and important effect
size, it will take appropriately-designed impact studies to
demonstrate whether subgrouping does change practice
and improve outcomes in routine care settings. Only
where all these criteria are satisfied can evidence-based
clinical guidelines confidently recommend subgrouping
for routine care.
Summary
There is a need for a method framework for subgrouping
studies in low back pain due to considerable interest in
subgrouping and clinical prediction rules, a proliferation
of research methods, and variability in how subgroup
results are interpreted. The method framework presented
in this article is not prescriptive but is presented to fur-
ther conversation amongst researchers and clinicians
about a suitable roadmap with which to coherently plan,
stage, perform and evaluate subgrouping research. The
studies used as examples in this method framework were
from low back pain research but the methods are equally
applicable to neck pain and may also be applicable to
other musculoskeletal conditions. The suggested frame-
work provides a platform for modification and extension
by the research community, and needs to be regularly
updated as method evolves.
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